Cargando…

270 SYN-004, a Class A Beta-Lactamase Therapy for the Prevention of Antibiotic-Induced Disruption of Intestinal Microflora

Detalles Bibliográficos
Autores principales:	Kaleko, Michael, Bristol, Andrew, Connelly, Sheila, Koski, Pertti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781800/ http://dx.doi.org/10.1093/ofid/ofu052.136

Ejemplares similares

716 Risk Factors for Resistance to Beta-lactam/Beta-lactamase Inhibitors and Carbapenems in Bacteroides spp. Bacteremia
por: Smith, Janessa, et al.
Publicado: (2014)

488 Treatment Outcomes in Patients with Extended-Spectrum Beta-lactamase Producing Organisms
por: Lee, Eunbae, et al.
Publicado: (2014)

135 Fosfomycin Susceptibilities Among Uropathogenic Extended Spectrum Beta-Lactamase-producing Enterobacteriacea
por: Abbo, Lilian, et al.
Publicado: (2014)

694 Bone and joint infection due to bacteria producing Extended Broad Spectrum Beta lactamase
por: Rouzaud, Claire, et al.
Publicado: (2014)

256 S-649266, a Novel Siderophore Cephalosporin: Mechanisms of enhanced activity and beta-lactamase stability
por: Tsuji, Masakatsu, et al.
Publicado: (2014)

SYN-007, an Orally Administered Beta-Lactamase Enzyme, Protects the Gut Microbiome from Oral Amoxicillin/Clavulanate without Adversely Affecting Antibiotic Systemic Absorption in Dogs
por: Connelly, Sheila, et al.
Publicado: (2020)

152 One year impact of clindamycin and ciprofloxacin administration on the human normal microflora
por: Rashid, Mamun-Ur, et al.
Publicado: (2014)

343 Risk Factors for Extended-Spectrum Beta-Lactamase Infection and Evaluation of Carbapenem Use Patterns and Appropriateness in a County Hospital Setting
por: Su, Henry, et al.
Publicado: (2014)

486 Meropenem and Piperacillin-tazobactam have Comparable Outcomes in Treatment of Bloodstream Infections Caused by Extended Spectrum Beta-lactamase Producing E.coli and Klebsiellae
por: Harris, Patrick, et al.
Publicado: (2014)

479 Clinical outcomes in patients with extended-spectrum-beta-lactamase-producing (ESBL) Enterobacteriaceae bloodstream infections (ESB) treated with carbapenems (CP) and non-carbapenems (NC)
por: Chin, Judy, et al.
Publicado: (2014)

717 Clinical characteristics and outcome of metallo-β-lactamase-producing Enterobacter cloacae bacteremia at a tertiary care cancer center in Japan
por: Sasaki, Shugo
Publicado: (2014)

257 In Vitro Activity of Meropenem/RPX7009, a Carbapenem/β-lactamase Inhibitor Combination Tested Against Contemporary Populations of Enterobacteriaceae and KPC-producing Strains
por: Castanheira, Mariana, et al.
Publicado: (2014)

728 Evaluation of Empirical Regimens Including Antistaphylococal Beta-lactam Antibiotics vs Vancomycin Monotherapy on Outcomes of Patients with Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia
por: Terico, Adrienne, et al.
Publicado: (2014)

Low dose oral beta-lactamase protects the gut microbiome from oral beta-lactam-mediated damage in dogs
por: Connelly, Sheila, et al.
Publicado: (2019)

Oral Metallo-Beta-Lactamase Protects the Gut Microbiome From Carbapenem-Mediated Damage and Reduces Propagation of Antibiotic Resistance in Pigs
por: Connelly, Sheila, et al.
Publicado: (2019)

1468 Detection of High CSF Levels of (1 → 3)-Beta-D-Glucan in Cryptococcal Meningitis
por: Rhein, Joshua, et al.
Publicado: (2014)

757 Comparison of Nephrotoxicity in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Beta-lactams or Vancomycin
por: Streifel, Amber, et al.
Publicado: (2014)

1454 Antifungal Susceptibility Patterns of a Global Collection of Fungal Isolates and Polysorbate-80 Effect on the Susceptibility of the Antifungal Classes
por: Castanheira, Mariana, et al.
Publicado: (2014)

Oral Beta-Lactamase Protects the Canine Gut Microbiome from Oral Amoxicillin-Mediated Damage
por: Connelly, Sheila, et al.
Publicado: (2019)

181 Empiric Coverage of ICU Patients for Infections Due to Beta-lactam Resistant Pseudomonas aeruginosa with Combination Therapy: A Needs Assessment
por: Cawcutt, Kelly, et al.
Publicado: (2014)

642 Increased HIV Target Cells and Decreased HLA Class I Expression at the Oral Mucosa is Associated with Mixed Feeding of Infants in Khayelitsha, South Africa
por: Wood, Lianna, et al.
Publicado: (2014)

236 Taking an Antibiotic Timeout: Utilizing an Antibiotic Renewal Template for Automatic Approval of Vancomycin and Piperacillin-tazobactam
por: Graber, Christopher J., et al.
Publicado: (2014)

The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies
por: Kokai-Kun, John F., et al.
Publicado: (2017)

754 Improving antibiotic delivery in the ICU
por: Lakshmi, Seetha, et al.
Publicado: (2014)

147 An antibiotic stewardship program in the emergency department decreased piperacillin-tazobactam use and increased guideline-concordant antibiotic prescribing for uncomplicated cystitis
por: Haas, Michelle, et al.
Publicado: (2014)

782 The efficacy of anaerobe specific antibiotics in patients with aspiration pneumonia
por: Ban, Hirokazu, et al.
Publicado: (2014)

608 Can Rapid Molecular Diagnostics Assist in the Choice of b-Lactam Antibiotics? An Analysis of Data from PRIMERS-II of the Antibiotic Resistance Leadership Group (ARLG)
por: Hujer, Andrea M., et al.
Publicado: (2014)

390 Evaluating Guideline-Recommended Antibiotic Prescribing Practices: Azithromycin for what?
por: Wright, Heather, et al.
Publicado: (2014)

1327 Factors associated with optimizing empiric antibiotic therapy in six hospitals
por: Morgan, Daniel, et al.
Publicado: (2014)

370 The Impact of Early Life Antibiotic Exposure on Childhood Weight Gain
por: Gerber, Jeffrey S., et al.
Publicado: (2014)

1326 Validation of the Antibiotic Spectrum Score Method to Measure Antibiotic De-escalation (AD) Utilizing Electronic Bar Code Medication Admininstration Data in Patients with Healthcare Associated Pneumonia (HCAP)
por: Madaras-Kelly, Karl, et al.
Publicado: (2014)

388 Antibiotic Stewardship in the Neonatal Intensive Care Unit (NICU): Metrics Matter!
por: Cantey, Joseph, et al.
Publicado: (2014)

195 Rapid Intravenous Antibiotic Desensitization: Clinical Experience at a Single Center
por: Booher, Katelyn, et al.
Publicado: (2014)

491 Comparative Effectiveness of Single vs Combination Antibiotic Prophylaxis for TRUS-biopsy
por: Marino, Kaylee, et al.
Publicado: (2014)

338 Prevalence, Mortality and Outcomes of Antibiotic Therapy of Multi-Drug Resistant Acinetobacter baumannii
por: Lapensee, Kenneth T., et al.
Publicado: (2014)

1232 Antibiotic Stewardship for Urinary Tract Infections (UTI): Impact on Therapy and Clinical Outcomes
por: Gill, Veenu, et al.
Publicado: (2014)

739 Outcomes and pharmacoeconomic analysis of a home intravenous antibiotic infusion program in veterans
por: Ruh, Christine, et al.
Publicado: (2014)

1483 High Rate of Antibiotic Prescriptions for Outpatients with Influenza-Like Illness in Southern Sri Lanka
por: Tillekeratne, L. Gayani, et al.
Publicado: (2014)

973 Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients
por: Stevens, Vanessa, et al.
Publicado: (2014)

1794 Appropriate Antibiotic Therapy is Associated with Reduced Risk of Community Acquired Clostridium difficile Infection
por: Ge, Ivy Y., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9tpsjltdgd8r42g34tomah69u2